Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana

Table 4

Adjusted associations of patient characteristics and time to CD4+ T-lymphocyte recovery in 233 HIV-infected children on highly active antiretroviral therapy (HAART) from 2004–2009, Accra, Ghana.

Predictors	Hazard ratio (95% CL)	𝑃-value
Parental living status		.025
Both parents alive	1.98 (1.18, 3.35)
One parent known to be alive	2.00 (1.18, 3.38)
Both parents dead or unknown	1.00
Gender		.051
Female	1.37 (1.00, 1.87)
Male	1.00
Age category		.014
<12 months	0.98 (0.44, 2.20)
1–5 years	1.59 (1.15, 2.19)
>6 years	1.00
<12 months*	0.62 (0.28, 1.37)
1–5 years	1.00
WHO immune classification		<.0001
No evidence of suppression	2.31 (1.48, 3.63)
Evidence of moderate suppression	2.04 (1.46, 2.86)
Severe suppression	1.00

*Small sample size in children <12 months.